Berkeley Lab

Distinguished Women in Science Speaker Series

Past Events

Geri Richmond, Presidential Chair in Science and University of Oregon Professor of Chemistry – June 11, 2018

Bio: Geraldine (Geri) Richmond is the Presidential Chair in Science and Professor of Chemistry at the University of Oregon where she has been since 1985.   A native of Kansas, she received her undergraduate degree in chemistry from Kansas State University and her Ph.D. in physical chemistry from the University of California, Berkeley.  Her educational efforts have focussed largely on introductory chemistry and science literacy courses as well as being the director of several University of Oregon undergraduate research programs.  Her research examines the chemistry and physics that occurs at complex surfaces that have relevance to important problems in energy production, environmental remediation and atmospheric chemistry. Using a combination of laser-based methods and theoretical simulations her most recent efforts have focussed on understanding environmentally important processes at water surfaces. Over 200 publications have resulted from the studies conducted in her laboratory with undergraduate, graduate students and postdoctoral associates

 

Jennifer Doudna, Biochemist Faculty Scientist at Berkeley Lab; Professor, UC Berkeley; Principal Investigator, Howard Hughes Medical Institute – November 20, 2017

Bio: Jennifer Doudna is a Li Ka Shing Chancellor Chair Professor in the Department of Chemistry and the Department of Molecular and Cell Biology at the University of California, Berkeley. Doudna has been an investigator with the Howard Hughes Medical Institute (HHMI) since 1997, and since 2018 holds the position of senior investigator at the Gladstone Institutes as well as that of professor at the University of California, San Francisco. Doudna has been a leading figure in what is referred to as the “CRISPR revolution” for her fundamental work and leadership in developing CRISPR-mediated genome editing. In 2012, Doudna and Emmanuelle Charpentier were the first to propose that CRISPR/Cas9 (enzymes from bacteria that control microbial immunity) could be used for programmable editing of genomes, which is now considered one of the most significant discoveries in the history of biology.